Article Text

Download PDFPDF
Neurocysticercosis: mimics and chameleons
  1. Guillermo Delgado-García1,
  2. Víctor Alfonso Méndez-Zurita2,
  3. Leo Bayliss1,
  4. José Flores-Rivera1,3,
  5. Agnès Fleury2,4
  1. 1 Division of Neurology, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
  2. 2 Neurocysticercosis Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
  3. 3 Demyelinating Diseases Clinic, National Institute of Neurology and Neurosurgery, Mexico City, Mexico
  4. 4 Neuroinflammation Unit, Institute of Biomedical Research, National Autonomous, University of Mexico, Mexico City, Mexico
  1. Correspondence to Dr Agnès Fleury, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 4510, México; afleury{at}biomedicas.unam.mx

Abstract

Neurocysticercosis is the most common parasitic neurological disease worldwide, yet in Europe, it remains relatively uncommon, with many practitioners rarely seeing a case. However, immigration and international travel mean that it is becoming increasingly recognised and diagnosed in developed countries. Being a treatable condition, it is essential to be familiar with the diagnosis and to appreciate its mimics and breadth of its possible clinical presentations.

  • neurocysticercosis
  • differential diagnosis
  • tropical neurology
  • travel neurology
  • Infectious diseases

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Correction notice This article has been updated since it was published Online First. Several typographical errors have been corrected.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Commissioned. Externally peer reviewed by Aaron Berkowitz, Boston, USA.